Akorn-Strides sells product portfolio to Pfizer
Executive Summary
Pfizer Inc. is acquiring 16 ANDAs and six filed ANDAs from Akorn-Strides LLC (a 50/50 joint venture between Akorn Inc. and Strides Arcolab Ltd.).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice